United Therapeutics | UTHR - Trade Debtors

Stock Price
568.58
Daily Change
-7.21 -1.25%
Monthly
-2.06%
Yearly
86.21%
Q2 Forecast
557.15

United Therapeutics reported $312M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Amarin USD 126.83M 477K Dec/2025
Ardelyx USD 71.85M 4.76M Dec/2025
Baxter International USD 1.7B 310M Mar/2026
Bayer EUR 18.55B 4.36B Mar/2026
BioCryst Pharmaceuticals USD 106.82M 15.49M Dec/2025
Biogen USD 1.79B 76.6M Mar/2026
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Gilead Sciences USD 4.74B 172M Mar/2026
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Halozyme Therapeutics USD 457.99M 16.72M Mar/2026
Insmed USD 178.55M 37.7M Mar/2026
Ionis Pharmaceuticals USD 74M 8M Mar/2026
J&J USD 21.33B 3.72B Dec/2025
Lexicon Pharmaceuticals USD 2.38M 50K Dec/2025
Moderna USD 71M 113M Mar/2026
Omeros USD 8.08M 440K Jun/2024
Pfizer USD 16.17B 332M Mar/2026
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Sangamo BioSciences USD 581K 110K Jun/2024
Sarepta Therapeutics USD 547.91M 149.68M Mar/2026
Teva Pharmaceutical Industries USD 3.39B 316M Mar/2026
United Therapeutics USD 312M 38.2M Mar/2026
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026